Khosla Rachna 4
4 · AMGEN INC · Filed Nov 7, 2023
Insider Transaction Report
Form 4
AMGEN INCAMGN
Khosla Rachna
SVP, Business Development
Transactions
- Tax Payment
Common Stock
2023-11-05$269.86/sh−173$46,686→ 7,467 total - Tax Payment
Common Stock
2023-11-05$269.86/sh−144$38,860→ 7,323 total
Footnotes (2)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 102 RSUs which will vest on 5/5/2024; 252 RSUs which will vest in installments of 124 on 4/30/2024 and 128 on 4/30/2025; 784 RSUs which will vest in installments of 386 on 11/5/2024 and 398 on 11/5/2025; 606 RSUs which will vest in installments of 199 on 5/2/2024, 200 on 5/2/2025, and 207 on 5/2/2026; and 593 RSUs which will vest in in installments of 195 on 5/2/2025, 196 on 5/2/2026 and one installment of 202 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 130 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.